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Introduction
Urinary bladder diseases, most notably cystitis and bladder cancer, are important medical problems that generate high costs to the health systems worldwide. The bladder, ureters, renal pelvis, and part of the urethra are lined by the urothelium, a stratified epithelium reminiscent of the skin epidermis consisting of three cell types organized in 3-7 layers ( Figure 1A ). Basal cells are small, cuboid, and express CD44 and KRT5; a fraction thereof express KRT14 and have stem cell properties (Papafotiou et al., 2016) . Intermediate cells are larger, express KRT8, KRT18, and uroplakins UPK1a, 1b, 2, 3a and 3b. Luminal umbrella cells are largest, multinucleated, highly specialized cells expressing high levels of uroplakins and KRT20 (Hicks, 1965; Ho et al., 2012; Wu et al., 1990) . Umbrella cells constitute the physiological barrier to the passage of water, electrolytes, and urea through tight junctions, responsible for the high resistance paracellular pathway (Apodaca, 2004) . Unlike the skin epidermis, the urothelium has a very slow turnover (Jost, 1986) yet it preserves a robust capacity to restore epithelial integrity upon damage (Claysin and Cooper, 1969; Papafotiou et al., 2016) . Several key transcriptional factors involved in urothelial proliferation/differentiation have been identified using 2D cultures and genetic mouse models. PPARg is expressed in the urothelium throughout embryonic development and in the adult (Jain et al., 1998) and it has been shown to participate in proliferation, cooperating with FOXA1, KLF5, and EGFR signaling (Bell et al., 2011; Varley et al., 2009) . The role of these pathways in urothelial differentiation is incompletely understood, due to the lack of methods to continually propagate normal cells.
Three-dimensional (3D) organoids have become a powerful tool to study the molecular and cellular basis of epithelial differentiation, allowing consistent culture and perpetuation (Sato et al., 2009 ). Organoids are derived from stem/progenitor cells capable of self-renewal and selforganization through cell sorting and lineage commitment in an in vivo-like manner (Kretzschmar and Clevers, 2016) . The Clevers laboratory has pioneered the establishment of organoids from a wide variety of epithelia, including mouse small intestine (Sato et al., 2009) , liver (Huch et al., 2015) , prostate (Karthaus et al., 2014) , and pancreas (Boj et al., 2015) . Organoids facilitate studying tissue biology, modeling disease, drug screening, and establishing a solid basis for regenerative medicine and gene therapy (Fatehullah et al., 2016) . The majority of studies have focused on organoids derived from simple epithelia; work to understand urothelial biology and carcinogenesis lags behind.
Here, we harness the ability of ITGA6/CD49f-expressing (CD49 high ) urothelial stem cells to selfperpetuate as organoids, identify the critical pathways involved therein, and use transcriptomics to identify the role of the Notch pathway in urothelial differentiation. Figure   S1A ). EpCAM + cells cultured in Matrigel with complete medium (CM, including EGF, LY2157299, Noggin, WNT3A, RSPO1) (Clevers, 2016; Fatehullah et al., 2016) led to growth of multilayered organoids over one week. Organoids could be consistently passaged and maintained in culture uninterruptedly for >1 year with stable morphology and a tendency to become enriched in cells with basal features (Figure S1B-D) . To identify critical growth factors, we performed "Leave-one-out" experiments where we removed each CM component individually or in combination. At day 7, we observed a statistically significant reduction of organoid number upon omission of EGF, WNT3A, RSPO1, or WNT3A+RSPO1 (Figure 1B-C). As reported for other tissues, Noggin was not required to establish organoids but it was essential for long-term perpetuation (not shown) (Yin et al., 2014) .
Results

Normal
Despite their high proliferative potent, organoids did not form tumors upon xenotransplantation (not shown).
CD49f
high expression defines an organoid-forming urothelial cell population with stem cell features. To define the cell-type of origin of the organoids, we isolated urothelial cell subpopulations. Immunofluorescence analysis of normal urothelium showed that CD49f selectively labels basal cells ( Figure 1A ) (Liu et al., 2012) . Purified CD49f high cells were enriched in basal markers whereas CD49f low cells were relatively enriched in luminal markers ( Figure 1D ). We screened a panel of lectins (not shown) and found that umbrella cells are strongly labeled by Wheat germ agglutinin (WGA), unlike the remaining urothelial cells ( Figure 1A ). FACS-sorting EpCAM + cells using these markers and cell size -which diminishes towards the luminal cells -showed that Figure   1E ). CD44 has been proposed as a urothelial stem/basal cell marker (Chan et al., 2009; Ho et al., 2012 Figure F , S1E, and S1F). However, the number of organoids was significantly higher in the CD49f high /CD44 high population (P=0.029) ( Figure 1G ). Lowdensity seeding and mixing experiments using EGFP-and Tomato-labeled cells showed the monoclonality of the organoids ( Figure 1H -I). Altogether, these results indicate that CD49f high labels the organoid-forming urothelial cell population. Combined EGFR inhibition and PPARg activation drive urothelial organoid differentiation. We used the PPARg agonist Roziglitazone (Rz) and the EGFR inhibitor Erlotinib to determine if they could further induce urothelial differentiation. NMU-o-P cultured for an additional 7 days in the presence of Rz+Erlotinib acquired larger lumina and showed significantly lower KI67 labeling and higher UPK3A expression, compared to untreated NMU-o-P ( Figure 3A -B). Cd49f and Cd44 mRNAs were down-regulated while uroplakin transcripts were up-regulated ( Figure 3C ). In NMU-o-D, Rz or Erlotinib alone caused reduced expression of Cd49f and Cd44 mRNAs ( Figure   S3B ). When combined, they led to highest Foxa1 and uroplakin mRNAs expression and to a significant reduction of lumen formation. There were no major changes in KI67 and cleaved-caspase Transcriptome analysis of differentiated NMU-o reveals novel pathways activated during urothelial differentiation. To interrogate the transcriptomic programs governing NMU-o differentiation we performed RNA-seq of 3 independent paired P and D organoid cultures ( Figure   S4A ). Principal component analysis showed that NMU-o-P clustered closely whereas NMU-o-D showed greater transcriptome divergence ( Figure S4B ); 4100 genes were differentially expressed between both conditions (FDR<0.05; Table S1 ). Among the top up-regulated transcripts in NMU-o-P were those involved in cell cycle (i.e. Cdk1, Aurkb, Ccnb2, and Ki67), inhibition of apoptosis (Birc5) Promoter motif analysis of differentially expressed genes using ISMARA revealed significant enrichment in motifs of TF involved in proliferation (E2F, MYC, MYB) and hypoxia regulation (HIF1A) in NMU-o-P. By contrast, NMU-o-D showed enrichment of chromatin regulators (EZH2, IKZF1, CHD1), Hippo pathway (TEAD3, TEAD4), and epithelial-mesenchymal transition regulators (SNAI1, ZEB1, ZEB2) ( Figure S4G ). Gene set enrichment analysis (GSEA) revealed a highly significant down-regulation of the activity of pathways involved in cell cycle, DNA repair, RNA biology, protein synthesis, and cytokine biology in NMU-o-D; this was accompanied by increased activity of epithelial differentiation/cell-cell adhesion, intracellular traffic (endocytosis, lysosome), and signaling (Notch, phosphatidylinositol, Wnt, MAPK, mTOR) ( Figure 4E and Table S2 ). The porcupine inhibitor IWP-2 reduced Wnt pathway activity and had a modest effect on organoid morphology ( Figure 4F-H) .
NMU-o recapitulate
Importantly, the g-secretase inhibitor DAPT significantly reduced expression of Notch target genes and Upk3a, and it completely abrogated lumen formation ( Figure 4F -G,I, and not shown), supporting the notion that this pathway plays a crucial role in urothelial differentiation.
Discussion
The identification of normal urothelial stem cells and establishment of conditions for their selfrenewal and differentiation is key to an improved understanding of homeostasis and dysregulation in disease. We show that Cd49f labels a subpopulation of basal urothelial cells with stem cell properties and long-term growth potential that largely recapitulates urothelial differentiation, allowing us to uncover new pathways involved therein and providing an important resource for cell biology studies and approaches to regenerative medicine. Alpha2 beta1 and alpha3 beta1 integrins are also markers of skin epidermal stem cells (Jones et al., 1995) , underscoring that similar hierarchies exist in stratified epithelia despite fundamental differences in proliferation dynamics. Further analysis of Cd49f high cell heterogeneity should help identify subpopulations with highest self-renewal potential.
There is a remarkable parallelism between the crucial growth pathways involved in urothelial stem cell renewal and those involved in bladder cancer. NMU-o displaying a basal phenotype are critically dependent on EGF for growth and basal/squamous-like bladder tumors show EGFR pathway deregulation, mainly through EGFR amplification (Rebouissou et al., 2014) . Wnt ligands are required for optimal urothelial organoid growth, consistent with in vivo data indicating that stromal Wnt induced by epithelial Shh is required for urothelial recovery from damage impinged by infection or chemical injury (Shin et al., 2011) . RNA-seq analysis showed up-regulation of Wnt factor mRNA expression in NMU-o-D and Wnt pathway inhibition reduced the number of lumen-containing organoids, suggesting that epithelial-autonomous Wnt production could contribute to urothelial differentiation. In bladder cancer, genes involved in Wnt signaling are rarely mutated but are frequently deregulated through deletion and/or epigenetic regulation (Stoehr et al., 2004) . A role for Wnt has been proposed on the basis of the cooperation of mutant beta-catenin with Pten deletion or
HRas activation in mice (Ahmad et al., 2011a (Ahmad et al., , 2011b .
We of KRT20 expression. We speculate that multinucleation, mechanical forces involved in bladder wall distension, and exposure to urine may additionally contribute to regulate KRT20 expression.
PPARg has been proposed to play a key role in urothelial differentiation. Previous studies using 2D cultures had shown that cells with self-propagating capacity lost the ability to respond to PPARg agonists (Georgopoulos et al., 2011) . By contrast, the organoids we describe here undergo with of epithelial-to-mesenchymal features (Maraver et al., 2015) . These results indicate that Notch supports differentiation in normal urothelium and that its inactivation is co-opted during carcinogenesis to promote the development of poorly differentiated tumors.
The identification of a urothelial stem cell population able to form organoids with differentiation capacity, together with single cell analyses, should facilitate the study of the molecular pathophysiology of bladder diseases, including the interaction of epithelial cells with pathogens, and the dissection of the molecular mechanisms through which oncogenes and tumor suppressors contribute to bladder cancer. 
Cell lines
VMCUB-2 cells cultured in basic DMEM were used as a positive control for the xenograft experiments. L-Wnt3a cells transfected with the Wnt3A cDNA were used to produce Wnt3A conditioned medium (Jung et al., 2011) . RSPO-1 was supplemented as the conditioned medium of Expi293 cells transfected with a pOPINE-G-RSPO1-His6 plasmid (a kind gift of Dr. E. Batlle, IRB Barcelona) using the ExpiFectamine™ 293 Transfection Kit. The activity of both conditioned media was confirmed by testing their effect on Axin2 mRNA expression by HeLa cells using RT-qPCR. Murine macrophage RAW 264.7 cells were maintained in Dulbecco's Modified Eagle's medium (DMEM), supplemented with 10% FBS, 1% sodium pyruvate and 1% penicillin/streptomycin (basic DMEM). For selected experiments, cells were seeded at 70% confluence in basic DMEM supplemented with oxLDL (15μg/mL) alone or with either Roziglitazone (10μM) or T0070907 (2μM). After 2h, cells were cultured with basic DMEM supplemented with oxLDL (15μg/mL). After 48h, RNA was extracted. All cells were allowed to settle in a humidified incubator at 37 ºC, 5% CO2. All cell lines used were Mycoplasma-free.
Establishment of normal mouse organoids
Mice were sacrificed and the bladder was accessed and turned inside-out leaving the urothelial surface exposed. The urothelium was enzymatically digested with collagenase P (0.5μg/mL) in Hank's Balanced Salt Solution (HBSS) in a thermoblock with gentle shaking at 37 ºC for 20 min. Collagenase P was inactivated with 2mM EDTA and 50% FBS. The cell suspension was collected and the remaining urothelium was scraped. After filtering through a 70μm strainer (Falcon) and centrifugation at 1200rpm for 5min at 4 ºC, the pellet was washed 2x (Advanced DMEM F12 medium + 1x HEPES + 1x Glutamax-washing medium) and cells were embedded in Matrigel (growth factorreduced and phenol red-free): Matrigel-cell suspensions (20 μL drops) were plated onto 6-well plates, allowed to settle in a humidified incubator at 37 ºC/5% CO2, and overlaid with 2mL complete medium (see below), changed every 2-3 days. Cultures were usually expanded at a 1:4-1:6 ratio every 7-10 days. After Matrigel removal with Corning® Cell Recovery Solution on ice, the cell suspension was washed with PBS, then with washing medium, and centrifuged at 1200rpm for 5min at 4 ºC. Then, NMU-o were chemically digested with Dispase II solution (10mg/mL) (Gibco) for 15-20min in a rotating wheel at room temperature. The reaction was neutralized with 2mM EDTA and single cells were obtained by mechanical disruption with a syringe with a 21G needle for at least strokes. After 2 washes with washing medium, the pellet was embedded in fresh ice-cold Matrigel, plated on 6-well plates, and covered with medium as described. Unless otherwise specified, NMU-o were maintained in culture with complete medium [Advanced DMEM/F12, 1x penicillin/streptomycin, 1x HEPES, 1x GlutaMAX, 50% WNT3A conditioned medium, 5% human RSPO1 conditioned medium, 1x N2 (Gibco), 1x B27 (Gibco), 50ng/mL human recombinant EGF (Invitrogen), 1mM Nacetylcysteine (Sigma-Aldrich), 50μg/mL human Noggin (Peprotech) and 1μM LY-2157299 (AxonChem)]. The ROCK inhibitor Y-27632 (10μM) (Sigma-Aldrich) was added during the first 3 days of culture. For differentiation experiments, NMU-o were cultured for the first 7 days in complete medium, reseeded (without disaggregation) in fresh Matrigel, and cultured either with complete medium or with differentiation medium (lacking WNTA3A and RSPO-1 conditioned medium, EGF, LY-2157299 and Noggin) for the following 7 days. PPARg pathway modulators were added to the medium (complete or differentiated) as indicated in the text, at the following concentrations: Rosiglitazone (1μM), T0070907 (10μM), Erlotinib (0.5μM). The γ-secretase inhibitor DAPT (5μM) and IWP-2 (5μM) were added on day 7 to NMU-o-P and cultures were allowed to grow under differentiation medium until day 14. Microphotographs were taken using an inverted microscope (Olympus CK-30). In order to cryopreserve NMU-o, 7 day cultures were washed once in PBS, Corning® Cell Recovery Solution was added, and cells were collected and placed on ice for 30min. After washing once with PBS, then with washing medium, and centrifugation at 1200 rpm 4 ºC for 5 min, organoids were resuspended in freezing media (10% DMSO in Advanced DMEM/F12 supplemented with 10µM Y-27632) at a density equivalent to 3 confluent drops/500µL. Cryovials were stored at -80 ºC. For thawing, vials were placed in a 37 ºC water bath and the contents washed twice with Advanced DMEM/F12 before reseeding in Matrigel at the required density.
METHODS DETAILS
Flow cytometry analysis of isolated urothelial cells and NMU-o. Urothelial cell suspensions obtained as previously described were incubated with blocking buffer (1% BSA/3mM EDTA in PBS) for 15 min at room temperature. After washing twice with PBS, cells were incubated with FITClabeled anti-EpCAM, APC-labeled anti-EpCAM, FITC-labeled WGA, PE-labeled anti-CD49f, APClabeled anti-CD45, PE-labeled anti-CD31, PE-labeled anti-CD14a, PE-labeled anti-Ter119 and/or APC-labeled anti-CD44 antibodies in FACS buffer (0.1%BSA/3mM EDTA in PBS) for 30 min at 4 ºC. After washing twice with PBS, cells were resuspended in FACS buffer and stained with DAPI (Sigma-Aldrich). In all the experiments a control sample lacking primary antibody and a Fluorescence Minus One (FMO) control were used. In the experiments from isolated urothelial cells, EpCAM+ single cells were sorted by FACS and dead cells were excluded from subsequent analyses. In the experiments with NMU-o, samples were disaggregated as previously mentioned and single cell suspensions were incubated with PE-labeled anti-CD49f antibodies. In the case of D<70µm and D>70µm, NMU-o-P at day 7 were filtered using a 70µm filter and the fallthrough and the retained organoids were reseeded in Matrigel and cultured in differentiation medium. All samples were analysed using a FACS Influx or AriaII (BD Biosciences) flow cytometer and at least 10,000 events were acquired. Analyses were performed using FlowJo flow cytometer analysis software.
